Your browser doesn't support javascript.
loading
Optimization of PDE3A Modulators for SLFN12-Dependent Cancer Cell Killing.
Lewis, Timothy A; de Waal, Luc; Wu, Xiaoyun; Youngsaye, Willmen; Wengner, Antje; Kopitz, Charlotte; Lange, Martin; Gradl, Stefan; Ellermann, Manuel; Lienau, Philip; Schreiber, Stuart L; Greulich, Heidi; Meyerson, Matthew.
Afiliação
  • Lewis TA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
  • de Waal L; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
  • Wu X; Dana-Farber Cancer Institute, Boston, Massachusetts 01255, United States.
  • Youngsaye W; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
  • Wengner A; Dana-Farber Cancer Institute, Boston, Massachusetts 01255, United States.
  • Kopitz C; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
  • Lange M; Bayer AG, Berlin, Germany.
  • Gradl S; Bayer AG, Berlin, Germany.
  • Ellermann M; Bayer AG, Berlin, Germany.
  • Lienau P; Bayer AG, Berlin, Germany.
  • Schreiber SL; Bayer AG, Berlin, Germany.
  • Greulich H; Bayer AG, Berlin, Germany.
  • Meyerson M; Broad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
ACS Med Chem Lett ; 10(11): 1537-1542, 2019 Nov 14.
Article em En | MEDLINE | ID: mdl-31749907
ABSTRACT
6-(4-(Diethylamino)-3-nitrophenyl)-5-methyl-4,5-dihydropyridazin-3(2H)-one, or DNMDP, potently and selectively inhibits phosphodiesterases 3A and 3B (PDE3A and PDE3B) and kills cancer cells by inducing PDE3A/B interactions with SFLN12. The structure-activity relationship (SAR) of DNMDP analogs was evaluated using a phenotypic viability assay, resulting in several compounds with suitable pharmacokinetic properties for in vivo analysis. One of these compounds, BRD9500, was active in an SK-MEL-3 xenograft model of cancer.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: ACS Med Chem Lett Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos